Orskov C, Wettergren A, Holst JJ
Russell-Jones D, Vaag A, Schmitz O, et al
Wium-Andersen IK, Osler M, Jrgensen MB et al (2019) Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested casecontrol study
Future studies are needed to improve our understanding of the underlying molecular pathways
However, its efficacy and safety are largely dependent on the education and support provided to facilitate self-management [5, 6]
Tolerability Issues : The adverse events with the GLP-1-based therapies are primarily gastrointestinal and include nausea, vomiting, constipation, or diarrhea [82], leading to meaningful discontinuation rates that limit real-world effectiveness